Drug Side Effects
Search
GENETIC POLYMORPHISM
GENETIC POLYMORPHISM
was reported 57 times
GENETIC POLYMORPHISM is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
16
0.0007
1
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
24
0.0005
2
Cytomegalovirus pUL97 Kinase Inhibitor [EPC]
1
0.0004
3
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
25
0.0002
4
Antiparasitic [EPC]
1
0.0002
5
Pediculicide [EPC]
1
0.0002
6
Interleukin-1 Receptor Antagonist [EPC]
1
0.0001
7
Complement Inhibitor [EPC]
3
0.0001
8
Human Immunoglobulin G [EPC]
1
0.0000
9
Protease Inhibitor [EPC]
2
0.0000
10
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
11
Provitamin D2 Compound [EPC]
1
0.0000
12
Cytochrome P450 3A Inhibitor [EPC]
2
0.0000
13
Sympathomimetic-like Agent [EPC]
1
0.0000
14
Mood Stabilizer [EPC]
6
0.0000
15
Anti-epileptic Agent [EPC]
6
0.0000
16
Erythropoiesis-stimulating Agent [EPC]
1
0.0000
17
Topoisomerase Inhibitor [EPC]
1
0.0000
18
Nucleoside Analog Antiviral [EPC]
1
0.0000
19
Atypical Antipsychotic [EPC]
5
0.0000
20
Benzodiazepine [EPC]
7
0.0000
21
Calcineurin Inhibitor Immunosuppressant [EPC]
1
0.0000
22
Interleukin-6 Receptor Antagonist [EPC]
1
0.0000
23
Calcium [EPC]
1
0.0000
24
Azole Antifungal [EPC]
1
0.0000
25
Estrogen [EPC]
1
0.0000
26
RANK Ligand Inhibitor [EPC]
1
0.0000
27
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
28
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
29
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
30
Loop Diuretic [EPC]
1
0.0000
31
Proton Pump Inhibitor [EPC]
1
0.0000
32
Corticosteroid [EPC]
2
0.0000
33
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000